Milestone Scientific Signs U.S. Distribution Agreement for the CompuFlo Epidural System with Clinical Technology

Milestone Scientific (NYSE: MLSS), a developer of computerized drug delivery instruments that provide painless and precise injections, today announced it has signed an agreement with Clinical Technology, a leading specialty distributor of medical products in the mid-western region of the United States, for the CompuFlo Epidural System.

As quoted in the press release:

Kent Krafft, Vice President of Clinical Technology Inc., stated, “We are impressed with Milestone Scientific’s CompuFlo^® Epidural System following extensive due diligence prior to entering this agreement.  We have several instruments on loan with top anesthesiologists and have received positive feedback from both providers and patients, reinforcing our confidence in this disruptive technology.   Knowing the precise location of a needle during an epidural procedure provides a measure of safety not available to medical professionals using conventional syringes that rely on subjective perception to identify the epidural space. We look forward to rolling out the CompuFlo^® Epidural System across the Midwest.”

Sharon Smith, Executive Vice President of Global Sales and Marketing of Milestone Scientific, commented, “We are pleased to partner with CTI in the Midwest. CTI will be an asset to Milestone as we aggressively educate medical professionals on the benefits of objective, quantifiable and real-time confirmation of accessing the epidural space and build a new standard of care with of the CompuFlo^® Epidural Instrument.”

Click here to read the full press release.